Emergent BioSolutions Reports Q1 2024 Financial Results and Workforce Reduction

DENVER, Colo., May 02, 2024 (247marketnews.com)- Emergent BioSolutions Inc. (NYSE:EBS) reported it first quarter financial results and upgraded its 2024 forecast.

Its first quarter 2024 total revenues of $300.4 million exceeded the prior guidance range, while generating $9.0 million in 2024 first quarter net income and adjusted EBITDA of $66.9 million

“We delivered a strong quarter with growth across all our key products,” commented Emergent President and CEO, Joe Papa. “We also took significant actions to improve our debt position, reduce operating expenses and strengthen our financial flexibility. Emergent’s transformation will not happen overnight. The actions we are implementing today, combined with the assets Emergent possesses, will enable us to move faster, reach farther and be more nimble. The public health threats we collectively face are changing, and so is Emergent.”

Emergent increased the lower range of its full year 2024 financial forecast from $900 – $1,100 million to $1,000 – $1,100.

Emergent BioSolutions also announced the next phase of its new operational plan that consolidates operations, closes several manufacturing facilities, and restructures its enterprise workforce, which is expected to deliver annual cost savings of approximately $80 million

“Today’s actions are about the future of Emergent,” stated Papa. “We have put in place a multi-year plan to position Emergent for sustainable and long-term success, and that starts by stabilizing our operations, strengthening our balance sheet and managing our debt.

“Decisions like these are never easy as they have real impact on many of our dedicated colleagues. We are committed to providing resources to those affected as they transition to new opportunities.”

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (EBS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.